登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
收藏
Figshare
2023-07-14 更新
2026-04-28 收录
弥漫性中线胶质瘤
用药研究
数据链接:
https://figshare.com/articles/dataset/Supplementary_Data_from_ONC201_in_Combination_with_Paxalisib_for_the_Treatment_of_H3K27-Altered_Diffuse_Midline_Glioma/30700393
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
All Supplementary Tables
所有补充表格
应用场景:
创建时间:
2023-07-14
相关数据集
Monitoring the Future: A Continuing Study of the Lifestyles and Values of Youth, 1987
青少年研究
用药研究
This is the thirteenth annual survey in this series that explores changes in important values, behaviors, and lifestyle orientations of contemporary American youth. The students are randomly assigned
DataCite Commons
2026-03-11 更新
9
0
Additional file 3 of Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor
弥漫性中线胶质瘤
肿瘤克隆进化
Additional file3. Supplementary tables.
NIAID Data Ecosystem
5
0
系统评估适龄早产防治方案对于高龄孕妇早产防治效果研究的数据集
妊娠并发症
用药研究
该数据集选取早产高危孕妇为研究对象,采用病例对照研究,阐明治疗的药物,比如阿司匹林、阿托西班和地塞米松等药物的最佳应用时机、剂量和疗程等,目的是探索适合高龄孕妇的早产防治方案,阿司匹林组病例数为3724例,阿托西班组的病例数是65例,地塞米松组的病例数是1309例。
国家人口健康科学数据中心
4
0
Progesterone Acts Synergistically with Niraparib in Ovarian Cancer by Promoting Ferroptosis via the PR/SCD1/ Fatty Acid Oxidation Pathway
代谢机制
用药研究
Cells seeded were administered niraparib, niraparib + P4 or vehicle control for 24 h. Cells were collected by trypsinization and centrifugation.
NIAID Data Ecosystem
6
0
Disease and medications characteristics of the participants.
临床特征分析
用药研究
Disease and medications characteristics of the participants.
NIAID Data Ecosystem
5
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广